Drug Report History #97485
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v6-FR | Version v1-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2020-02-05 (Updated) | 2019-10-30 |
| Drug Identification Number | 02035626 | 02035626 |
| Brand name | OPTIRAY 320 (ULTRAJECT) | OPTIRAY 320 (ULTRAJECT) |
| Common or Proper name | Ioversol Injection 68% | Ioversol Injection 68% |
| Company Name | LIEBEL-FLARSHEIM CANADA INC | LIEBEL-FLARSHEIM CANADA INC |
| Ingredients | IOVERSOL | IOVERSOL |
| Strength(s) | 68% | 68% |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVASCULAR | INTRAVASCULAR |
| Packaging size | 125 ml | 125 ml |
| ATC code | V08AB | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2019-10-30 | 2019-10-30 |
| Estimated end date | 2020-01-30 | 2020-01-30 |
| Actual end date | 2020-01-17 (Updated) | |
| Shortage status | Resolved (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | For more information, please contact Methapharm Inc. at 1-800-287-7686, [email protected]. | For more information, please contact Methapharm Inc. at 1-800-287-7686, [email protected]. |
| Health Canada comments |